Skip to main content

Headline Roundup March 11th, 2020

Delays, Confusion Mark Coronavirus Testing in US

Summary from the AllSides News Team

Confusion is widespread in the U.S. regarding the availability and effectiveness of testing for the COVID-19 coronavirus. Many reporting outlets from all perspectives have focused on the apparent lack of effective testing available in the U.S. and problems with the treatment process overall. Some sites are pointing directly to facts about symptoms, testing and treatment.

Featured Coverage of this Story

Nurses Who Fear They Have The Coronavirus Have Waited Up To A Week For Test Results
Nurses Who Fear They Have The Coronavirus Have Waited Up To A Week For Test Results

BuzzFeed News

News

Nurses worried they were infected with COVID-19 told BuzzFeed News they waited up to a week to get test results, despite displaying symptoms and being health care professionals on the front line.

"I'm a registered nurse who knows how to navigate the system, and I'm having trouble getting answers," a nurse from Sacramento told BuzzFeed News. "Members of the general public certainly must be faring much, much worse."

Open on BuzzFeed News
Coronavirus tests are now more available. But a key testing component is in short supply.
Coronavirus tests are now more available. But a key testing component is in short supply.

USA TODAY

News

A new shortage of a key testing component is hobbling the U.S. battle against COVID-19 as the number of confirmed coronavirus cases continues to rise.

Earlier testing was marred by problems that produced potentially inaccurate results. Now, as U.S. testing ramps up, some labs have run short on the kits and components needed to determine whether samples taken from ailing patients confirm the presence of the novel coronavirus.

The problem is emerging as the number of confirmed COVID-19 cases in the U.S. rose to 1,050, with 29 deaths, as of...

Open on USA TODAY
How Government Red Tape Stymied Testing and Made the Coronavirus Epidemic Worse
How Government Red Tape Stymied Testing and Made the Coronavirus Epidemic Worse

Reason

Analysis

The United States is home to the most innovative biotech companies and university research laboratories in the world. That fact should have given our country a huge advantage with respect to detecting and monitoring emerging cases of COVID-19 caused by the new coronavirus outbreak.

Instead, as The New York Times reports in a terrific new article, officials at the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) stymied private and academic development of diagnostic tests that might have provided an early warning and a...

Open on Reason

More headline roundups

More News about Coronavirus on AllSides

News from the Left

News from the Center

News from the Right